Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
Add Yahoo as a preferred source to see more of our stories on Google. Medtronic said Monday it received 510(k) clearance from the Food and Drug Administration for an app to connect its smart insulin ...
Medtronic (NYSE:MDT) has launched its MiniMed Go Smart MDI system with the Simplera sensor in Europe. The system connects the InPen smart insulin pen and a continuous glucose sensor into a single ...
With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete diabetes management system aimed at people taking multiple insulin injections per ...
Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...
More than a year after Medtronic released its MiniMed Connect system, which connects an insulin pump and affiliated CGM to a smartphone app, the company has launched an Android version of the MiniMed ...
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...
DUBLIN, -- Medtronic plc, the global leader in medical technology, today announced the initiation of the DEFINE AFib study, the company's first app-based research study. Using data collected from the ...
Medical technology provider Medtronic and Fitbit joined forces to create a mobile app to help patients with diabetes better track their blood glucose levels and sync data from their wearable devices ...
With the COVID-19 pandemic still making it difficult to initiate studies in research centers, virtual clinical studies have become all the rage—and Medtronic is hopping on the bandwagon. The medtech ...
Medtronic added a predictive feature to Sugar.IQ, its diabetes management app. Medtronic released Sugar.IQ in partnership with IBM Watson Health in June. The Sugar.IQ app, which is available to users ...
Medtronic plc kicked off an app-based research study to improve understanding of atrial fibrillation (AF) disease burden and its impact on patient outcomes, quality of life and health care utilization ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results